John Docherty
Net worth: 35 790 $ as of 2026-05-30
Net worth: 35 790 $ as of 2026-05-30
John Martin Docherty is currently President, Chief Scientific Officer & Director at Lexaria Bioscience Corp.
since 2015.
Formerly, Mr. Docherty was President & Director at PharmaDerm Laboratories Ltd. from 2004 to 2008 and President & Chief Operating Officer at Helix BioPharma Corp.
from 2007 to 2013.
Education includes undergraduate and graduate degrees from the University of Toronto, conferred in 1993 and 1995 respectively.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-11-30 | 59,451 ( 0.24% ) | 35 790 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | President | 2015-04-14 |
| Companies | Position | End |
|---|---|---|
| HELIX BIOPHARMA CORP. | President | 2013-11-30 |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. | President | 2008-06-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Helix BioPharma Corp.
Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. Pharmaceuticals: MajorHealth Technology Engages in drug delivery technology | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. |
Select your edition
All financial news and data tailored to specific country editions